Showing results (41-50 of 141) with videos related to
Sort By:
Pageof 15
International Journal of Vascular Medicine|August 1, 2012
Anti-inflammatory effects of epoxyeicosatrienoic acidsScott J Thomson, Ara Askari, David Bishop-BaileyPharmacology & Therapeutics|September 20, 2005
Peroxisome proliferator-activated receptors and inflammationLeonardo A Moraes, Laura Piqueras, David Bishop-BaileyProceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Expression and activation of the farnesoid X receptor in the vasculatureDavid Bishop-Bailey, Desmond T Walsh, Timothy D WarnerJournal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alphaPanagiotis S Kabouridis, Maemunah Hasan, Justine Newson, et al.Current Opinion in Allergy and Clinical Immunology|December 14, 2011
Dissecting the role of eosinophil cationic protein in upper airway diseaseJonas Bystrom, Smita Y Patel, Kawa Amin, et al.Fundamental & Clinical Pharmacology|June 30, 2010
Inhibition of the diclofenac-induced cyclooxygenase-2 activity by paracetamol in cultured macrophages is not related to the intracellular lipid hydroperoxide toneSamir S Ayoub, Amrish Joshi, Mary Chol, et al.Blood|September 14, 2011
Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female miceRamona S Scotland, Melanie J Stables, Shimona Madalli, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 9, 2004
A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammationDerek W Gilroy, Justine Newson, Prescilla Sawmynaden, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 13, 2006
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2Timothy D Warner, Ivana Vojnovic, David Bishop-Bailey, et al.International Journal of Molecular Sciences|January 19, 2019
AZD1208, a Pan-Pim Kinase Inhibitor, Has Anti-Growth Effect on 93T449 Human Liposarcoma Cells via Control of the Expression and Phosphorylation of Pim-3, mTOR, 4EBP-1, S6, STAT-3 and AMPKAnil Kumar Yadav, Vinoth Kumar, David Bishop Bailey, et al.Pageof 15